First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02186366
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Menghan Li

Active Ingredients

Drugs in Other Trials (2)

buspirone (buspar) (1 trial)

fluoxetine (prozac) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2